Medical Doctor Program year 2021 Reported 2020–2021 Source: CMS Open Payments, 2026 publication

Sharad Bhatt

Geriatric Psychiatry North Canton, OH Medical Doctor

NPI 1235161951 CMS profile 328471

907 S Main St, North Canton, OH 44720

Open in the dashboard

General payments

$64

2 records reported · program years 2020–2021

Research payments

$0

Paid to them · None reported · program years 2020–2021

Ownership & investment interest

$0

None reported

Through program year 2021, Sharad Bhatt of North Canton, OH is reported in the CMS Open Payments database as having received $64 across 2 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 18th percentile of Geriatric Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

2 rows
Year Kind Relative to this record's peak year Amount Records
2021 General $64 1
2020 General $0 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Sharad Bhatt
  • Geriatric Psychiatry median
  • Middle half of Geriatric Psychiatry
  • National median

In program year 2025, general payments to Sharad Bhatt were reported at $0. Among 188 Geriatric Psychiatry profiles paid that year, the median was $125 and the middle half received between $52 and $515.

Show as a table
Year Sharad Bhatt Geriatric Psychiatry median Middle half National median
2019 $0 $151 $47–$484 $163
2020 $0 $112 $30–$410 $114
2021 $64 $122 $35–$550 $132
2022 $0 $133 $54–$557 $149
2023 $0 $138 $61–$485 $160
2024 $0 $127 $51–$572 $164
2025 $0 $125 $52–$515 $169

Breakdown

Who paid General payments · program years 2020–2021
  1. Alkermes, Inc. $64 1 payment
  2. Validus Pharmaceuticals LLC $0 1 payment

Every payment, record by record

What the payments were for General payments · program years 2020–2021
  1. Food and Beverage $64 1 payment
  2. Gift $0 1 payment
Products named General payments · program years 2020–2021
  1. ARISTADA Cns $64 1 payment
  2. ARISTADA Cns $64 1 payment
  3. ARISTADA Cns $64 1 payment
  4. ARISTADA Cns $64 1 payment
  5. ARISTADA INITIO $64 1 payment
  6. Zolpimist $0 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 47 drugs

Part D claims

2,841

Median for Psychiatry: 574

Drug cost

$129,918

Median for Psychiatry: $27,624

Branded share of claims

18.9%

Median for Psychiatry: 17%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Wellbutrin Xl Bupropion Hcl Brand 11 $58,757
Trintellix Vortioxetine Hydrobromide Brand 37 $24,467
Methylphenidate Er Methylphenidate Hcl Brand 19 $4,743
Tegretol Xr Carbamazepine Brand 12 $3,413
Alprazolam Generic 442 $3,012
Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine Brand 72 $2,838
Oxcarbazepine Generic 88 $2,702
Clonazepam Generic 225 $2,384
Aripiprazole Generic 49 $1,921
Duloxetine Hcl Generic 100 $1,773

The 10 drugs with the highest cost, of 47 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 20,488 Part D prescribers listed as Psychiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 5 billing codes

Paid by Medicare

$7,405

Medicare's payments for the services billed

Medicare patients

37

Average age 62

Services billed

142

26 women, 11 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Depression 65%
High blood pressure 57%
Arthritis 35%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

2 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Geriatric Psychiatry in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2021

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record